During the past decade, Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 30 clinical trials were completed, i.e. on average, 61.2% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 20 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi" #1 sponsor was "Janssen Research & Development, LLC" with 11 trials, followed by "Celgene" with 9 trials sponsored, "Takeda" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Gilead Sciences" with 5 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator and "Pharmacyclics LLC." with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi" are "Chronic Lymphocytic Leukemia" (5 trials), "Acute Myeloid Leukemia" (3 trials), "Leukemia, Myeloid, Acute" (3 trials), "Lymphoma, Mantle-Cell" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi" in a lesser frequency.

Most popular intervention types in "Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi" are "Drug" (67 trials), "Biological" (8 trials), "Other" (7 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Rituximab" (7 trials), "Carboplatin" (5 trials), "Lenalidomide" (5 trials) and "Venetoclax" (5 trials). Other intervention names were less common.

The vast majority of trials in "Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi" are 64 trials for "All" genders, 8 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi". undefined are not yet recruiting, 19 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi has several departments that took part in Clinical trials: "Woj.Wielospecjalistyczne Centrum Onkologii i Traumatologii; Oddz.Hematologii Pododz.Chemioterapii" - 5 trials, "Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii; Poradnia Chemioterapii" - 4 trials, "Regional Oncological Center, Dept. of Chemotherapy" - 2 trials, "Uniwersytecki Szpital Kliniczny im WAM CSW; Klinika Nefrologii i Transplantologii Nerek" - 2 trials